Investec Bank plc has filed a public dealing disclosure under Rule 8.5 of the Takeover Code relating to Advanced Medical Solutions Group Plc (AMS.L).
The disclosure identifies Investec as an exempt principal trader acting in a client-serving capacity with recognised intermediary status under the Code.
Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group plc, establishing its connection to the party named in the filing.
The dealings covered in the disclosure were undertaken on 23rd June 2026, with the formal disclosure date recorded as 24th June 2026.
On the purchase side, Investec handled transactions covering 340,461 ordinary shares, with prices ranging from a low of 230 pence to a high of 240 pence per unit.
On the sales side, a slightly larger volume of 341,961 ordinary shares was transacted, also within the same price range of 230 to 240 pence per unit.
The marginal difference between shares purchased and shares sold reflects typical market-making activity carried out by an exempt principal trader operating in a client-serving role.
No cash-settled derivative transactions, stock-settled derivative transactions, or options activity was reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or understandings that could serve as an inducement to deal or refrain from dealing in connection with the offer.
Similarly, no agreements relating to voting rights, future acquisition, or disposal of relevant securities through derivatives were disclosed, with both sections formally recorded as none.
The contact named in the filing is Priyali Bhattacharjee, reachable by telephone, and the disclosure was submitted in accordance with regulatory requirements for public filings under Rule 8 of the Takeover Code.
Advanced Medical Solutions Group Plc shares traded with a decline of 2.04 percent on the day the disclosure was published, reflecting broader market movements around the stock.
